Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2015

View Archived Issues

Pfizer reflects on milestones of third quarter 2015

Charleston Laboratories and Daiichi Sankyo report data from phase III study of CL-108

Emory University divulges AEP inhibitors

Immunovaccine's RSV candidate is well tolerated in phase I trial

Ultragenyx and Arcturus collaborate to develop mRNA therapeutics for rare diseases

7-Methylxanthine reduces myopia progression in children

Nano-diamino-tetraiodothyroacetic acid named orphan drug in the U.S.

OncoSec Medical starts biomarker study of ImmunoPulse IL-12 in triple-negative breast cancer

Preclinical studies of Shigellosis-typhoid bivalent vaccine

Sumitomo Dainippon offers overview of second quarter of fiscal 2015

MedImmune discloses anti-IL-21 MAbs

Zhejiang University and Shanghai Institute of Materia Medica patent proteasome inhibitors

Bayer Schering Pharma reports CDK9/cyclin-T1 inhibitors

Sanofi introduces GPR119 agonists

Isis Pharmaceuticals divulges SOD-1 modified ASOs

Ferring's Rekovelle MAA filing accepted by EMA

Mochida files NDA for MD-0901 for ulcerative colitis in Japan

Memory and learning deficits restored using neurotrophic factor mimetic in AD aged mice

PLX-3397 receives FDA breakthrough therapy designation for tenosynovial giant cell tumor

Porcupine inhibitor blocks growth of Wnt-upregulated tumors in mice

Researchers create refined animal model of experimental autoimmune encephalomyelitis

Canbex Therapeutics initiates phase II trial of VSN-16R for spasticity in MS

Cellceutix updates status of brilacidin program

Novel assay for the diagnosis of MKD demonstrates 100% accuracy

Chugai describes phase I candidate PTH1 receptor agonist PCO-371

Merck KGaA and Selvita extend cancer drug discovery collaboration

AbbVie applies for approval of new indication for Humira in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...